SEATTLE – Sage Bionetworks and Celgene Corporation have introduced Journey PRO, a mobile health research study designed to improve the understanding of disease burden on people living with chronic anemia due to myelodyspastic syndromes, myelofibrosis and beta-thalassemia. The study is using mobile and wearable technologies to quantify the daily burden of chronic anemia on patients living with these diseases. “Journey PRO will provide direct and immediate information back to research participants to help them manage their health,” said Lara Mangravite, president of Sage Bionetworks, in a statement. Participants will be able to use the Journey PRO mobile app to track key health data and schedule appointment dates. They will also be able to visualize their study data, and can choose to download the data and share it with their health care team.
You are here: / / mHealth study to focus on chronic anemia